These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 13498184)

  • 1. Pharmacological and biological psychotherapy.
    HEATH RG; LEACH BE; BYERS LW; MARTENS S; FEIGLEY CA
    Am J Psychiatry; 1958 Feb; 114(8):683-9. PubMed ID: 13498184
    [No Abstract]   [Full Text] [Related]  

  • 2. [Schizophrenia and cerebral amines].
    Véron JP; Kezirian S
    Presse Med (1893); 1971 Oct; 79(44):1973-4. PubMed ID: 5119550
    [No Abstract]   [Full Text] [Related]  

  • 3. Metabolism of biogenic amines and psychotropic drug effects in schizophrenic patients.
    Brune GG
    Prog Brain Res; 1965; 16():81-96. PubMed ID: 5319089
    [No Abstract]   [Full Text] [Related]  

  • 4. [Neuropsychiatric diseases and amino acid metabolism].
    Kakimoto Y
    Nihon Rinsho; 1966 Jan; 24(1):23-30. PubMed ID: 5336582
    [No Abstract]   [Full Text] [Related]  

  • 5. Excretion of indoleamines in schizophrenia.
    Bueno JR; Himwich HE
    Int J Neurol; 1967; 6(1):65-76. PubMed ID: 5622712
    [No Abstract]   [Full Text] [Related]  

  • 6. The significance of some biochemical abnormalities in schizophrenia.
    Rodnight R
    Acta Neurol (Napoli); 1975; 30(1):85-101. PubMed ID: 1063539
    [No Abstract]   [Full Text] [Related]  

  • 7. [Biology and therapy of schizophrenia].
    Buscaino VM
    Acta Neurol (Napoli); 1970; 25(1):1-58. PubMed ID: 5444984
    [No Abstract]   [Full Text] [Related]  

  • 8. Current biochemical approaches to schizophrenia.
    Kety SS
    N Engl J Med; 1967 Feb; 276(6):325-31. PubMed ID: 5334111
    [No Abstract]   [Full Text] [Related]  

  • 9. Methylation & schizophrenia.
    Beaton JM
    Ala J Med Sci; 1975 Apr; 12(2):193-202. PubMed ID: 1096652
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cerebral amines].
    Nihon Rinsho; 1976 Sep; 34(9):2746-62. PubMed ID: 11360
    [No Abstract]   [Full Text] [Related]  

  • 11. Letter: Amines and theories in psychiatry.
    Boulton AA
    Lancet; 1974 Jul; 2(7871):52-3. PubMed ID: 4134443
    [No Abstract]   [Full Text] [Related]  

  • 12. Possible relation of central amines to behavior in schizophrenic patients.
    KETY SS
    Fed Proc; 1961 Dec; 20():894-6. PubMed ID: 14455441
    [No Abstract]   [Full Text] [Related]  

  • 13. Etiology of the stimulant nature of the schizophrenias.
    Pfeiffer CC; Beck RA; Goldstein L; Neiss ES
    Recent Adv Biol Psychiatry; 1966; 9():241-9. PubMed ID: 4878860
    [No Abstract]   [Full Text] [Related]  

  • 14. Comments on a proposed mechanism of formation of the "schizophrenic odor factor".
    Grant FW
    Res Commun Chem Pathol Pharmacol; 1973 Jul; 6(1):335-6. PubMed ID: 4734009
    [No Abstract]   [Full Text] [Related]  

  • 15. The minimal brain dysfunction syndrome.
    Wender PH
    Annu Rev Med; 1975; 26():45-62. PubMed ID: 1096774
    [No Abstract]   [Full Text] [Related]  

  • 16. [Methylation of biogenic amines in schizophrenia].
    Trzebiatowska-Trzeciak O; Trzeciak WH
    Psychiatr Pol; 1970; 4(6):671-6. PubMed ID: 5533633
    [No Abstract]   [Full Text] [Related]  

  • 17. Indolealkylamines and behavior.
    Airaksinen MM; McIsaac WM
    Ann Med Exp Biol Fenn; 1968; 46(3):367-81. PubMed ID: 4896939
    [No Abstract]   [Full Text] [Related]  

  • 18. Biogenic amines in Rett syndrome: the usual suspects.
    Roux JC; Villard L
    Behav Genet; 2010 Jan; 40(1):59-75. PubMed ID: 19851857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Schizophrenia].
    Guilmot PH
    Brux Med; 1972 Nov; 52(11):749-53. PubMed ID: 4654572
    [No Abstract]   [Full Text] [Related]  

  • 20. [Biologically active amines and schizophrenia (author's transl)].
    Toru M
    Tanpakushitsu Kakusan Koso; 1981 Aug; 26(11):1809-18. PubMed ID: 6117928
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.